| Faculty |
Research |
Phone / Location |
Umesh Desai, Ph.D.
urdesai@vcu.edu |
antithrombin activators, serpin mechanism |
828-8486 Smith./ 828-7328 Bio Tech |
| Smith Bldg. 542/ Bio TechI 212 |
Malgorzata Dukat, Ph.D.
mdukat@vcu.edu |
nicotinic cholinergic receptors, serotonin receptors |
225-3806 |
| Smith Bldg. 526 |
Richard A. Glennon, Ph.D.
glennon@vcu.edu |
serotonergic and cholinergic ligands, mechanisms of action of drugs of abuse |
828-8487 |
| Smith Bldg. 554 |
John C. Hackett, Ph.D., R.Ph.
jchackett@vcu.edu |
computational chemistry, biomolecular dynamics, biological reactive intermediates, drug design |
828-5679 |
| BioTechI 212 |
Glen E. Kellogg, Ph.D.
gekellog@vcu.edu |
molecular modeling and 3D-QSAR |
828-6452 |
| BioTechI 212 |
Jason Rife, Ph.D.
jprife@vcu.edu |
molecular modeling of RNA-drug interactions |
828-7488 |
| BioTechI 212 |
Martin Safo, Ph.D.
msafo@vcu.edu |
anti-sickling agents, molecular modeling |
828-7291 |
| BioTechI 212 |
Richard B. Westkaemper, Ph.D.
rbwestka@vcu.edu |
G protein-coupled receptors, neurotransmitter receptor structure modeling |
828-6449 |
| Smith Bldg 544 |
Bradford Windle, Ph.D.
bwindle@vcu.edu |
bioinformatic approaches to drug development |
628-1956 |
| Massey/Goodwin 319 |
Richard Young, Ph.D.
ryoung@vcu.edu |
drugs of abuse and behavior |
828-7403 |
| Smith Bldg 538 |
Shijun Zhang, Ph.D.
szhang2@vcu.edu |
Bifunctional ß Amyloid inhibitors, ERK2 kinase inhibitors as anti-cancer agents |
628-8266 |
| McGuire Annex Room 125 |
Yan Zhang, Ph.D.
yzhang2@vcu.edu |
chemokine receptors, opioid receptors, molecular modeling of G-protein coupled receptors |
828-0021 |
| Smith Bldg 534 |